Dr. Lincoln Nadauld, Executive Director of Precision Genomics at Intermountain Healthcare, defined precision genomics for us this week at HIMSS in just 15 words, “It means picking treatments for patients with cancer based on DNA changes in their cancer.” Simply put precision genomics, also called precision medicine, is a targeted way to attack cancer, and it works! Learn the ins and outs of this high-profile treatment in these videos.
Question: Is precision medicine really making a difference in patients’ lives?
Answer: Absolutely, and here is a real life success story. Watch the video below for Dr. Nadauld’s full answer.
Question: Is precision genomics progressing fast enough?
Answer: There is some tension from patients that the field of precision medicine is not progressing fast enough, but in order to progress we need to generate more data to demonstrate its positive outcomes. I think we are progressing at the right speed to meet patient and data needs. Watch the video below for Dr. Nadauld’s full answer.
Question: What cancers are most treatable with precision medicine?
Answer: Really, any cancer! Watch the video below for Dr. Nadauld’s full answer.
Question: How is Intermountain Precision Genomics involved with the White House Precision Medicine Initiative?
Answer: The White House Precision Medicine Initiative is a huge data collection exercise that will monitor and collect data on a million patients over a decade. Intermountain will be a part of this process, but take it a step further. We are taking that data, analyzing it, and then applying precision medicine treatments. It is the entire end-to-end process punctuated by delivering treatment. Watch the video below for Dr. Nadauld’s full answer.